Mirna Therapeutics, Inc.
2150 Woodward Street
Suite 100
Austin
Texas
78744
United States
Tel: 512-901-0900
Fax: 512-681-5201
Website: http://www.mirnatherapeutics.com/
Email: info@mirnatherapeutics.com
77 articles about Mirna Therapeutics, Inc.
-
Synlogic Completes Merger With Mirna
8/28/2017
-
Mirna Announces Results Of Annual Meeting Of Stockholders
8/25/2017
-
The End Of The Road: Mirna To Cease Operations After Merger With Synlogic
5/17/2017
-
Mirna Reports First Quarter 2017 Financial Results
5/10/2017
-
Mirna Reports Financial Results For The Fourth Quarter And Full Year Ended December 31, 2016
3/15/2017
-
Mirna Reports Third Quarter 2016 Financial Results And MRX34 Clinical Program Updates
11/11/2016
-
Mirna Halts Clinical Study of Lead Drug After Patients Get Sick
9/21/2016
-
Mirna To Participate In Two Healthcare Investor Conferences In September
8/31/2016
-
Mirna Reports Second Quarter 2016 Financial Results And Program Updates
8/15/2016
-
Mirna To Present At Cantor Fitzgerald’s 2nd Annual Healthcare Conference
7/5/2016
-
Mirna Appoints Perry Nisen, M.D., Ph.D., To Its Board Of Directors
6/30/2016
-
ASCO2016: Mirna Announces Clinical Data On Its Lead Microrna Therapeutic Presented At ASCO
6/6/2016
-
Mirna Reports First Quarter 2016 Financial Results And Program Updates
5/13/2016
-
Mirna Appoints Vincent J. O’Neill, M.D., As Chief Medical Officer
4/25/2016
-
Mirna Provides Operational Update And Reports Financial Results For Fourth Quarter And Full Year Ended December 31, 2015
3/30/2016
-
Mirna To Host Conference Call And Webcast Of Fourth Quarter And Full Year 2015 Financial Results On March 29, 2016
3/22/2016
-
Mirna To Present At The BIO CEO & Investor And LEERINK Global Healthcare Conferences In February
2/3/2016
-
Mirna To Present At The BIO CEO & Investor And LEERINK Global Healthcare Conferences In February
2/3/2016
-
Mirna Appoints Peter Greenleaf To Its Board Of Directors
2/1/2016
-
Rosetta Genomics Ltd. Grants Sublicenses To Mirna For MicroRNA-Related Patents For The Development Of Oncology Therapeutics
1/6/2016